Phytochemicals With Anti 5-Alpha-Reductase Activity: A Prospect for Prostate Cancer Treatment

    June 2021 in “ F1000Research
    Aziemah Azizi, Nuramalina H Mumin, N. Shafqat
    New to Phytosterols? There is a guide in the encyclopedia. Read the guide →
    Studysummary This review explores plant-derived phytochemicals, such as phytosterols, polyphenols, and fatty acids, for their potential use as alternative treatments for prostate cancer, emphasizing their effects on 5-alpha-Reductase enzyme isozymes. It reports no new clinical results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The review discussed the potential of phytochemicals, such as phytosterols, polyphenols, and fatty acids, as natural alternatives to synthetic 5-alpha-reductase inhibitors (5αRis) for prostate cancer treatment. Synthetic 5αRis like finasteride and dutasteride were effective but had adverse side effects, leading to interest in plant-derived compounds. Phytosterols like β-sitosterol and stigmasterol, and polyphenols like quercetin, myricetin, and fisetin, showed promise in inhibiting 5αR activity and reducing prostate tumor growth. Catechins from green tea also demonstrated potential as 5αR inhibitors. These findings suggested that phytochemicals could serve as complementary or alternative treatments for prostate cancer with fewer side effects than conventional medicines, highlighting the need for further research into these plant-based compounds.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results